About
CREATE Health, inaugurated in 2006 with a focus on precision medicine, is a strategic centre for translational research focusing on the early diagnosis and prognosis of cancer, as well as the development of novel treatment strategies.
Our vision: To accelerate translation of breakthrough therapies and diagnostics into clinical practice, improving outcomes for today´s cancer patients while building a healthier future for generations to come.
We will achieve our vision by the following missions:
- Innovate: Advance AI-driven, molecular profiling, precision biologics, analytics and targeted delivery systems to create earlier and more accurate interventions with less side effects.
- Translate: Rapidly move validated discoveries from the lab into clinical trials and practice based on solid evidence and regulatory strategy.
- Collaborate: Partner with clinicians, patients, industry and health systems to ensure that solutions are clinically relevant, scalable and equitable.
Our approach is translational - It starts from a specific need, identified by our clinical partners. We use novel technologies to find the relevant solutions, which can be implemented into the clinic with much shorter lead times.
Today CREATE Health consists of scientists from four different faculties: medicine, engineering, natural sciences and social sciences. It is hosted by LTH and located at Medicon Village in Lund. CREATE Health brings together, both physically and logistically, researchers from such diverse fields as bioinformatics, nanotechnology, proteomics, transcriptomics, cancer genetics and tumor cell biology with clinical oncologists from Lund University Hospital, thereby creating a unique integrative environment highly qualified for solving complex clinical problems.
